Innate Pharma SA

IPHA ·Healthcare, Drug Manufacturers - General

SEC Filings

Form	Filed	Description
6-K	Jun 4, 2024	6-K
6-K	May 28, 2024	6-K
6-K	May 24, 2024	6-K
6-K	May 23, 2024	6-K
6-K	May 15, 2024	6-K
6-K	May 14, 2024	6-K
6-K	May 7, 2024	6-K
6-K	Apr 15, 2024	6-K
6-K	Apr 15, 2024	6-K
6-K	Apr 10, 2024	6-K
20-F	Apr 4, 2024	20-F
6-K	Mar 21, 2024	6-K
6-K	Mar 21, 2024	6-K
6-K	Mar 19, 2024	6-K
6-K	Mar 14, 2024	6-K
6-K	Mar 6, 2024	6-K
6-K	Mar 6, 2024	6-K
6-K	Feb 21, 2024	6-K
6-K	Feb 6, 2024	6-K
424B5	Feb 6, 2024	424B5
EFFECT	Jan 16, 2024
6-K	Jan 12, 2024	INNATE PHARMA S.A. 6-K
CORRESP	Jan 11, 2024
6-K	Jan 5, 2024	INNATE PHARMA S.A. 6-K
6-K	Jan 4, 2024	INNATE PHARMA S.A. 6-K

← Newer Page 5 of 14 · 332 filings Older →